Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

NCT00063401 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Peritoneal Neoplasms
Fallopian Tube Neoplasms

Interventions

BIOLOGICAL: Cetuximab:
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]